Assessment of prognostic factors in previously treated Japanese patients with metastatic renal cell carcinoma who received nivolumab: An observational multi‑institute study

Molecular and Clinical Oncology ◽

10.3892/mco.2021.2446 ◽

2021 ◽

Vol 16 (1) ◽

Author(s):

Toshiki Ito ◽

Kosuke Mizutani ◽

Kiyoshi Takahara ◽

Ryosuke Ando ◽

Takahiro Yasui ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Japanese Patients ◽

Previously Treated

Download Full-text

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2004.07.004 ◽

2004 ◽

Vol 22 (5) ◽

pp. 432-433

Author(s):

Donald L. Trump

Keyword(s):

New York ◽

Renal Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Solid Tumor ◽

Cancer Center ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

PROGNOSTIC FACTORS IN PATIENTS WITH NON-METASTATIC RENAL CELL CARCINOMA

The Japanese Journal of Urology ◽

10.5980/jpnjurol1989.87.1099 ◽

1996 ◽

Vol 87 (9) ◽

pp. 1099-1104

Author(s):

Hideshi Inomiya ◽

Shigeo Isaka ◽

Tatsuya Okano ◽

Jun Shimazaki ◽

Tatsuo Igarashi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Download Full-text

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

The Lancet Oncology ◽

10.1016/s1470-2045(21)00241-2 ◽

2021 ◽

Author(s):

Chung-Han Lee ◽

Amishi Yogesh Shah ◽

Drew Rasco ◽

Arpit Rao ◽

Matthew H Taylor ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Treatment Naïve ◽

Previously Treated ◽

Download Full-text

Prognostic factors for survival in metastatic renal cell carcinoma

Cancer ◽

10.1002/cncr.24226 ◽

2009 ◽

Vol 115 (S10) ◽

pp. 2273-2281 ◽

Author(s):

Ronald M. Bukowski

Keyword(s):

Renal Cell Carcinoma ◽

Prognostic Factors ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Download Full-text

How does targeted immunotherapy compare with standard targeted therapy for people with previously treated metastatic renal cell carcinoma?

Cochrane Clinical Answers ◽

10.1002/cca.2629 ◽

2019 ◽

Author(s):

Jane Burch ◽

Gustavo Villalobos

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Previously Treated ◽

Targeted Immunotherapy

Download Full-text

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1262-8 ◽

2010 ◽

Vol 66 (6) ◽

pp. 1065-1070 ◽

Author(s):

Seiji Naito ◽

Taiji Tsukamoto ◽

Michiyuki Usami ◽

Hiroyuki Fujimoto ◽

Hideyuki Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Early Phase ◽

Phase Ii Trial ◽

Japanese Patients

Download Full-text

Efficacy of anti‑PD‑1 antibody nivolumab in Japanese patients with metastatic renal cell carcinoma: A retrospective multicenter analysis

Molecular and Clinical Oncology ◽

10.3892/mco.2019.1887 ◽

2019 ◽

Author(s):

Kazuyuki Numakura ◽

Yohei Horikawa ◽

Sachiko Kamada ◽

Atsushi Koizumi ◽

Taketoshi Nara ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Japanese Patients ◽

Multicenter Analysis

Download Full-text

Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2011.08.009 ◽

2013 ◽

Vol 31 (7) ◽

pp. 1276-1282 ◽

Author(s):

Nobuo Shinohara ◽

Takashige Abe ◽

Tango Mochizuki ◽

Akira Kashiwagi ◽

Kouichi Kanagawa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Japanese Patients ◽

Risk Classification ◽

Download Full-text

7147 Efficacy and safety of long-term use of sorafenib: final report of a phase II trial of sorafenib in Japanese patients with unresectable/metastatic renal cell carcinoma

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71480-6 ◽

2009 ◽

Vol 7 (2) ◽

pp. 437-438 ◽

Author(s):

H. Akaza ◽

S. Naito ◽

T. Tsukamoto ◽

M. Murai ◽

K. Fukino

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Phase Ii Trial ◽

Japanese Patients ◽

Final Report ◽

Efficacy And Safety

Download Full-text

Clinical Activity and Safety of Anti-Programmed Death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in Patients (PTS) with Previously Treated, Metastatic Renal Cell Carcinoma (MRCC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33350-0 ◽

2012 ◽

Vol 23 ◽

pp. ix258-ix259 ◽

Author(s):

D.F. McDermott ◽

C.G. Drake ◽

M. Sznol ◽

T.K. Choueiri ◽

J.D. Powderly ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Clinical Activity ◽

Programmed Death ◽

Programmed Death 1 ◽

Previously Treated

Download Full-text